多形性膠芽腫治療の世界市場は、2020年には約21億4,000万USドルとなり、2021年から2027年の予測期間には8.6%以上の健全な成長率が見込まれています。多形性膠芽腫は、ヒトの脳内で発生する重篤な癌です。世界の多形性膠芽腫治療市場は、多形性膠芽腫の有病率の上昇と脳腫瘍の発生率の増加によって牽引されています。さらに、研究開発の活発化や、新規治療法や併用療法の承認率の上昇は、世界の多形性膠芽腫治療業界に新たな機会をもたらすでしょう。例えば、National Brain Tumor societyによると、2020年の1年間にアメリカでは70万人が原発性脳腫瘍に苦しんでおり、2021年の年末までにさらに約8万5千人が診断されると予想されています。また、2019年6月には、アバスチンのバイオシミラーであるPfizer社のZirabevを米国FDAが承認し、再発性膠芽腫、大腸癌、NSCLCなどの治療に使用されています。また、2020年7月には、デノボ・バイオファーマ社のDB102（エンザスタウリン）に対して、新たに膠芽腫と診断された患者さんの治療を目的としたファストトラック承認の指定が米国FDAから認められました。このように、新規治療法や併用療法の承認が増えることが、今後の多形性膠芽腫治療業界の起爆剤になると考えられます。しかし、多形性膠芽腫に対する有効な治療法がなく、薬剤の開発に伴う高コストや厳しい規制が、2021年から2027年の予測期間における市場の成長を妨げる可能性があります。
多形性膠芽腫治療の世界市場では、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域が主要地域とされています。医療分野の発展を目的とした政府の強力な支援、希少疾患に対する意識の高まり、質の高い医療施設へのアクセスのしやすさなどから、北アメリカは世界の市場シェアでトップの地域となっています。アジア太平洋地域は、2021年から2027年の予測期間において、最も高い成長率を示すと予想されています。これは、テモゾロミド（temozolomide）のジェネリック医薬品の市場参入、経済の改善、高齢者人口の増加、医療分野への投資の増加などによるものです。
この調査の目的は、近年のさまざまなセグメントおよび国々の市場規模を定義し、今後8年間の価値を予測することです。本レポートは、調査対象となる各地域・国における産業の質的・量的側面を取り込むように設計されています。さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合状況や製品内容の詳細な分析とともに、利害関係者が投資できるミクロ市場での機会についても報告します。
目次
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Glioblastoma Multiforme Treatment Market , by Region, 2019-2027 (USD Billion)
1.2.2. Glioblastoma Multiforme Treatment Market , by Treatment , 2019-2027 (USD Billion)
1.2.3. Glioblastoma Multiforme Treatment Market , by Drug class, 2019-2027 (USD Billion)
1.2.4. Glioblastoma Multiforme Treatment Market , by End use, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Glioblastoma Multiforme Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Glioblastoma Multiforme Treatment Market Dynamics
3.1. Glioblastoma Multiforme Treatment Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of glioblastoma multiforme
3.1.1.2. Increase in incidences of brain tumours
3.1.2. Market Restraint
3.1.2.1. Lack of effective therapies for glioblastoma multiforme
3.1.2.2. High cost associated with the development of drug and stringent regulations
3.1.3. Market Opportunities
3.1.3.1. Growth in rate of approval for novel therapy and combination therapy
Chapter 4. Global Glioblastoma Multiforme Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Glioblastoma Multiforme Treatment Market , by Treatment
5.1. Market Snapshot
5.2. Global Glioblastoma Multiforme Treatment Market by Treatment , Performance - Potential Analysis
5.3. Global Glioblastoma Multiforme Treatment Market Estimates & Forecasts by Treatment 2018-2027 (USD Billion)
5.4. Glioblastoma Multiforme Treatment Market , Sub Segment Analysis
5.4.1. Surgery
5.4.2. Radiation Therapy
5.4.3. Chemotherapy
5.4.4. Targeted Therapy
5.4.5. Tumor Treating Fields Therapy
5.4.6. Immunotherapy
Chapter 6. Global Glioblastoma Multiforme Treatment Market , by Drug Class
a. Market Snapshot
6.1. Global Glioblastoma Multiforme Treatment Market by Drug Class, Performance - Potential Analysis
6.2. Global Glioblastoma Multiforme Treatment Market Estimates & Forecasts by Drug class2018-2027 (USD Billion)
6.3. Glioblastoma Multiforme Treatment Market , Sub Segment Analysis
6.3.1. Temozolomide
6.3.2. Bevacizumab
6.3.3. Lomustine
6.3.4. Carmustine Wafers
6.3.5. Others
Chapter 7. Global Glioblastoma Multiforme Treatment Market , by End use
b. Market Snapshot
7.1. Global Glioblastoma Multiforme Treatment Market by End use, Performance - Potential Analysis
7.2. Global Glioblastoma Multiforme Treatment Market Estimates & Forecasts by End use 2018-2027 (USD Billion)
7.3. Glioblastoma Multiforme Treatment Market , Sub Segment Analysis
7.3.1. Hospitals
7.3.2. Clinics
7.3.3. Ambulatory Surgical Centers
Chapter 8. Global Glioblastoma Multiforme Treatment Market , Regional Analysis
8.1. Glioblastoma Multiforme Treatment Market , Regional Market Snapshot
8.2. North America Glioblastoma Multiforme Treatment Market
8.2.1. U.S. Glioblastoma Multiforme Treatment Market
8.2.1.1. Treatment breakdown estimates & forecasts, 2018-2027
8.2.1.2. Drug class breakdown estimates & forecasts, 2018-2027
8.2.1.3. End use breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Glioblastoma Multiforme Treatment Market
8.3. Europe Glioblastoma Multiforme Treatment Market Snapshot
8.3.1. U.K. Glioblastoma Multiforme Treatment Market
8.3.2. Germany Glioblastoma Multiforme Treatment Market
8.3.3. France Glioblastoma Multiforme Treatment Market
8.3.4. Spain Glioblastoma Multiforme Treatment Market
8.3.5. Italy Glioblastoma Multiforme Treatment Market
8.3.6. Rest of Europe Glioblastoma Multiforme Treatment Market
8.4. Asia-Pacific Glioblastoma Multiforme Treatment Market Snapshot
8.4.1. China Glioblastoma Multiforme Treatment Market
8.4.2. India Glioblastoma Multiforme Treatment Market
8.4.3. Japan Glioblastoma Multiforme Treatment Market
8.4.4. Australia Glioblastoma Multiforme Treatment Market
8.4.5. South Korea Glioblastoma Multiforme Treatment Market
8.4.6. Rest of Asia Pacific Glioblastoma Multiforme Treatment Market
8.5. Latin America Glioblastoma Multiforme Treatment Market Snapshot
8.5.1. Brazil Glioblastoma Multiforme Treatment Market
8.5.2. Mexico Glioblastoma Multiforme Treatment Market
8.6. Rest of The World Glioblastoma Multiforme Treatment Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Merck & Co., Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Sumitomo Dainippon Pharma Oncology, Inc. (Boston Biomedical, Inc.)
9.2.3. Teva Pharmaceutical Industries Ltd.
9.2.4. Sun Pharmaceutical Industries Ltd.
9.2.5. Hoffmann-La Roche Ltd.
9.2.6. Pfizer, Inc.
9.2.7. Amgen, Inc.
9.2.8. Arbor Pharmaceuticals, LLC
9.2.9. Amneal Pharmaceuticals
9.2.10. Karyopharm Therapeutics, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
List of Tables
TABLE 2. Global Glioblastoma Multiforme Treatment Market , report scope
TABLE 3. Global Glioblastoma Multiforme Treatment Market estimates & forecasts by region 2018-2027 (USD Billion)
TABLE 4. Global Glioblastoma Multiforme Treatment Market estimates & forecasts by Treatment 2018-2027 (USD Billion)
TABLE 5. Global Glioblastoma Multiforme Treatment Market estimates & forecasts by Drug class2018-2027 (USD Billion)
TABLE 6. Global Glioblastoma Multiforme Treatment Market estimates & forecasts by End use 2018-2027 (USD Billion)
TABLE 7. Global Glioblastoma Multiforme Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Glioblastoma Multiforme Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Glioblastoma Multiforme Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Glioblastoma Multiforme Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Glioblastoma Multiforme Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Glioblastoma Multiforme Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Glioblastoma Multiforme Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Glioblastoma Multiforme Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Glioblastoma Multiforme Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. Global Glioblastoma Multiforme Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. Global Glioblastoma Multiforme Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 18. Global Glioblastoma Multiforme Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 19. Global Glioblastoma Multiforme Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Global Glioblastoma Multiforme Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 21. Global Glioblastoma Multiforme Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 22. Global Glioblastoma Multiforme Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 23. U.S. Glioblastoma Multiforme Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 24. U.S. Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 25. U.S. Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 26. Canada Glioblastoma Multiforme Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 27. Canada Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 28. Canada Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 29. UK Glioblastoma Multiforme Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 30. UK Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 31. UK Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 32. Germany Glioblastoma Multiforme Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 33. Germany Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 34. Germany Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 35. France Glioblastoma Multiforme Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 36. France Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 37. France Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 38. Spain Glioblastoma Multiforme Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 39. Spain Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 40. Spain Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 41. Italy Glioblastoma Multiforme Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 42. Italy Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 43. Italy Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 44. ROE Glioblastoma Multiforme Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 45. ROE Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 46. ROE Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 47. China Glioblastoma Multiforme Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 48. China Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 49. China Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 50. India Glioblastoma Multiforme Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 51. India Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 52. India Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 53. Japan Glioblastoma Multiforme Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 54. Japan Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 55. Japan Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 56. Australia Glioblastoma Multiforme Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 57. Australia Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 58. Australia Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 59. South Korea Glioblastoma Multiforme Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 60. South Korea Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 61. South Korea Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 62. ROPAC Glioblastoma Multiforme Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 63. ROPAC Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 64. ROPAC Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 65. Brazil Glioblastoma Multiforme Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 66. Brazil Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 67. Brazil Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 68. Mexico Glioblastoma Multiforme Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 69. Mexico Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 70. Mexico Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 71. ROLA Glioblastoma Multiforme Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 72. ROLA Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 73. ROLA Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 74. ROW Glioblastoma Multiforme Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 75. ROW Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 76. ROW Glioblastoma Multiforme Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 77. List of secondary sources used in the study of global Glioblastoma Multiforme Treatment Market .
TABLE 78. List of primary sources used in the study of global Glioblastoma Multiforme Treatment Market .
TABLE 79. Years considered for the study.
TABLE 80. Exchange rates considered.
List of figures
FIG 1. Global Glioblastoma Multiforme Treatment Market , research methodology
FIG 2. Global Glioblastoma Multiforme Treatment Market , market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Glioblastoma Multiforme Treatment Market , key trends 2020
FIG 5. Global Glioblastoma Multiforme Treatment Market , growth prospects 2021-2027
FIG 6. Global Glioblastoma Multiforme Treatment Market , porters 5 force model
FIG 7. Global Glioblastoma Multiforme Treatment Market , pest analysis
FIG 8. Global Glioblastoma Multiforme Treatment Market , value chain analysis
FIG 9. Global Glioblastoma Multiforme Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Glioblastoma Multiforme Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Glioblastoma Multiforme Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Glioblastoma Multiforme Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Glioblastoma Multiforme Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Glioblastoma Multiforme Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 15. Global Glioblastoma Multiforme Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 16. Global Glioblastoma Multiforme Treatment Market by segment, 2018 & 2027 (USD Billion)
FIG 17. Global Glioblastoma Multiforme Treatment Market , regional snapshot 2018 & 2027
FIG 18. North America Glioblastoma Multiforme Treatment Market 2018 & 2027 (USD Billion)
FIG 19. Europe Glioblastoma Multiforme Treatment Market 2018 & 2027 (USD Billion)
FIG 20. Asia-Pacific Glioblastoma Multiforme Treatment Market 2018 & 2027 (USD Billion)
FIG 21. Latin America Glioblastoma Multiforme Treatment Market 2018 & 2027 (USD Billion)
FIG 22. Global Glioblastoma Multiforme Treatment Market , company market share analysis (2020)
